Cost-effectiveness of chemoprophylaxis after occupational exposure to HIV.
Publication
, Journal Article
Frothingham, R
Published in: Arch Intern Med
July 13, 1998
Duke Scholars
Published In
Arch Intern Med
DOI
ISSN
0003-9926
Publication Date
July 13, 1998
Volume
158
Issue
13
Start / End Page
1470 / 1472
Location
United States
Related Subject Headings
- Zidovudine
- United States
- Occupational Exposure
- Lamivudine
- Indinavir
- Humans
- HIV Infections
- General & Internal Medicine
- Cost-Benefit Analysis
- Anti-HIV Agents
Citation
APA
Chicago
ICMJE
MLA
NLM
Frothingham, R. (1998). Cost-effectiveness of chemoprophylaxis after occupational exposure to HIV. Arch Intern Med, 158(13), 1470–1472. https://doi.org/10.1001/archinte.158.13.1470-a
Frothingham, R. “Cost-effectiveness of chemoprophylaxis after occupational exposure to HIV.” Arch Intern Med 158, no. 13 (July 13, 1998): 1470–72. https://doi.org/10.1001/archinte.158.13.1470-a.
Frothingham R. Cost-effectiveness of chemoprophylaxis after occupational exposure to HIV. Arch Intern Med. 1998 Jul 13;158(13):1470–2.
Frothingham, R. “Cost-effectiveness of chemoprophylaxis after occupational exposure to HIV.” Arch Intern Med, vol. 158, no. 13, July 1998, pp. 1470–72. Pubmed, doi:10.1001/archinte.158.13.1470-a.
Frothingham R. Cost-effectiveness of chemoprophylaxis after occupational exposure to HIV. Arch Intern Med. 1998 Jul 13;158(13):1470–1472.
Published In
Arch Intern Med
DOI
ISSN
0003-9926
Publication Date
July 13, 1998
Volume
158
Issue
13
Start / End Page
1470 / 1472
Location
United States
Related Subject Headings
- Zidovudine
- United States
- Occupational Exposure
- Lamivudine
- Indinavir
- Humans
- HIV Infections
- General & Internal Medicine
- Cost-Benefit Analysis
- Anti-HIV Agents